Atovaquone-d4
CAS: 2070015-14-2
Ref. 3D-VHD01514
| 1mg | Nachfragen | ||
| 5mg | Nachfragen | ||
| 10mg | Nachfragen | ||
| 25mg | Nachfragen | ||
| 50mg | Nachfragen |
Produktinformation
Atovaquone-d4 is an analog of atovaquone, a medication used to treat and prevent malaria. It is also being studied as a potential anticancer agent. Atovaquone-d4 works by inhibiting kinases, which are enzymes involved in cell signaling pathways that can contribute to cancer growth and survival. In Chinese hamster ovary cells, atovaquone-d4 has been shown to inhibit the activity of several different kinases, including those involved in regulating cell cycle progression and promoting cell survival. This inhibitor has also been found to induce apoptosis, or programmed cell death, in human cancer cells. Atovaquone-d4 is currently being investigated for its potential medicinal properties as an anticancer agent and may hold promise for future cancer treatments.
Chemische Eigenschaften
Technische Anfrage zu: 3D-VHD01514 Atovaquone-d4
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
